R-Biopharm launches as one of the first companies a real-time RT-PCR test for the detection of current coronavirus species

Today R-Biopharm launches the new RIDA®GENE SARS-CoV-2 RUO test for the detection of coronavirus SARS-CoV-2 from human respiratory samples.

As an innovative company we addressed the need to react to the threat of a coronavirus pandemic and developed the new RIDA®GENE SARS-CoV-2 RUO test that can be ordered from now on.

Key features of the RIDA®GENE SARS-CoV-2 RUO test:

• Real-time multiplex RT-PCR
• Time to result: less than 2 hours
• Detection of coronavirus SARS-CoV-2
• Qualitative detection of SARS-CoV-2 specific RNA from respiratory samples
• Flexible – the assays can be run on many commonly used real-time PCR instruments, such as the Mx3005P, LightCycler®480II, ABI 7500, CFX96 or Rotor-Gene Q or RIDA®CYCLER
• Reliable – an included extraction control (Internal control RNA, ICR) detects PCR inhibition, monitors reagent integrity and confirms that nucleic acid extraction was sufficient
• For research use only

For more information or ordering please contact your local sales representative.